An Organic Acid Disorder
What is it?
3-Methylcrotonyl-CoA Carboxylase Deficiency (3MCC) is a disorder in which the body cannot process certain proteins properly.
Inheritance and Frequency
The gene defect for 3-Methylcrotonyl-CoA
Carboxylase Deficiency (3MCC) is
an autosomal recessive genetic trait and is unknowingly passed down from
generation to generation. This faulty gene usually emerges when two carriers
have children together and pass it to their offspring. For each pregnancy
of two such carriers, there is a 25% chance that the child will be born with the
disease and a 50% chance the child will be a carrier for the gene defect.
3MCC affects approximately one in 50,000 people worldwide.
Signs & Symptoms
Symptoms may include hypotonia, muscle atrophy, seizures, and
dermatological changes.
Long Term Effects
Treatment
Dietary restrictions are the primary treatment; supplementation
with carnitine and/or biotin may be valuable.
History
Screening
Visit the What Does Your State Screen page to learn about your state's newborn screening program.
Supplemental
Screening
If you live in a state that
does not perform screening on its newborns for all detectable disorders, there
are laboratories that will provide this screening for you no matter your state of residence. For more information about supplemental screening,
visit our supplemental screening page. Also visit our frequently
asked questions page for more information on newborn screening.
Other Sites
of Reference
- Genetics Home Reference: 3-Methylcrotonyl-CoA Carboxylase Deficiency
- OMIM: 3-Methylcrotonyl-CoA Carboxylase Deficiency
Support
Groups
Organic Acidemia Association
13210 35th Avenue
Plymouth, MN 55441
Contact Person: Kathy Stagni
Phone: (763) 559-1797
Email: Write to OAA
HOME | ABOUT US | PRESS RELEASES | DONATE NOW | VOLUNTEER NOW
Contact
Save Babies Through Screening
for questions about the content of this site or
the Webmaster
for questions about technical issues related to this site.
Terms of use
for this site.
